Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)
Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –
Haemonetics operating margin
Operating margin is operating income as a percentage of revenue.
Haemonetics's operating margin for the twelve months ending Sep 26, 2026 was 12.8%. For fiscal 2026 it was 11.7%, against 16.3% the year before. The highest annual figure on record is 16.3% in fiscal 2011.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | 11.7% | −4.6 |
| FY2025 | Mar 29, 2025 | 16.3% | +3.7 |
| FY2024 | Mar 30, 2024 | 12.6% | −0.8 |
| FY2023 | Apr 1, 2023 | 13.4% | +5.2 |
| FY2022 | Apr 2, 2022 | 8.1% | −2.2 |
| FY2021 | Apr 3, 2021 | 10.3% | −0.1 |
| FY2020 | Mar 28, 2020 | 10.5% | +1.8 |
| FY2019 | Mar 30, 2019 | 8.6% | +2.4 |
| FY2018 | Mar 31, 2018 | 6.2% | +8.4 |
| FY2017 | Apr 1, 2017 | -2.2% | +2.6 |
| FY2016 | Apr 2, 2016 | -4.8% | −9.3 |
| FY2015 | Mar 28, 2015 | 4.5% | −0.5 |
| FY2014 | Mar 29, 2014 | 4.9% | −1.4 |
| FY2013 | Mar 30, 2013 | 6.3% | −5.9 |
| FY2012 | Mar 31, 2012 | 12.2% | −4.1 |
| FY2011 | Apr 2, 2011 | 16.3% | +3.4 |
| FY2010 | Apr 3, 2010 | 12.9% | −1.4 |
| FY2009 | Mar 28, 2009 | 14.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 26, 2026 | 21.0% | +3.1 |
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | 16.9% | +0.2 |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | -6.6% | −28.2 |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | 19.9% | +2.9 |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | 17.9% | +2.9 |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | 16.8% | +4.9 |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | 21.6% | +12.9 |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | 16.9% | +3.3 |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | 15.0% | +3.9 |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | 11.8% | −5.4 |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | 8.7% | −2.9 |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | 13.7% | −0.5 |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | 11.1% | −4.6 |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | 17.2% | +5.5 |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | 11.6% | +4.3 |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | 14.2% | +0.5 |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | 15.7% | +5.5 |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | 11.8% | +11.2 |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | 7.2% | +16.7 |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | 13.7% | −3.1 |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | 10.2% | −17.8 |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | 0.6% | −5.4 |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | -9.4% | −20.3 |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | 16.8% | +1.0 |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | 28.1% | +8.4 |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | 6.0% | +11.6 |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | 10.9% | +1.3 |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | 15.8% | +4.3 |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | 19.7% | +8.9 |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | -5.6% | −7.9 |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | 9.6% | +3.5 |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | 11.4% | +11.0 |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | 10.8% | +0.0 |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | 2.3% | −5.6 |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | 6.1% | +31.3 |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | 0.4% | −8.9 |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | 10.8% | – |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | 7.9% | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | -25.2% | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | 9.3% | – |
See a number that looks wrong?